135 related articles for article (PubMed ID: 32481313)
21. The effect of XPD/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis.
Xue H; Lu Y; Lin B; Chen J; Tang F; Huang G
PLoS One; 2012; 7(9):e43431. PubMed ID: 23028453
[TBL] [Abstract][Full Text] [Related]
22. XPD Lys751Gln polymorphisms and the risk of esophageal cancer: an updated meta-analysis.
Guo XF; Wang J; Lei XF; Zeng YP; Dong WG
Intern Med; 2015; 54(3):251-9. PubMed ID: 25748732
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studies.
Qin Q; Zhang C; Yang X; Zhu H; Yang B; Cai J; Cheng H; Ma J; Lu J; Zhan L; Liu J; Liu Z; Xu L; Sun X
PLoS One; 2013; 8(11):e79864. PubMed ID: 24260311
[TBL] [Abstract][Full Text] [Related]
24. The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis.
Du H; Guo N; Shi B; Zhang Q; Chen Z; Lu K; Shu Y; Chen T; Zhu L
PLoS One; 2014; 9(5):e96301. PubMed ID: 24787743
[TBL] [Abstract][Full Text] [Related]
25. Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis.
Zhao H; Wang LE; Li D; Chamberlain RM; Sturgis EM; Wei Q
Carcinogenesis; 2008 Aug; 29(8):1560-6. PubMed ID: 18635523
[TBL] [Abstract][Full Text] [Related]
26. Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies.
Wu KG; He XF; Li YH; Xie WB; Huang X
Tumour Biol; 2014 Nov; 35(11):11243-59. PubMed ID: 25113251
[TBL] [Abstract][Full Text] [Related]
27. Associations between XRCC2 rs3218536 and ERCC2 rs13181 polymorphisms and ovarian cancer.
Zhang W; Zhang Z
Oncotarget; 2016 Dec; 7(52):86621-86629. PubMed ID: 27863412
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population.
Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T
Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773
[TBL] [Abstract][Full Text] [Related]
29. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.
Qiu LX; Yao L; Zhang J; Zhu XD; Zhao XM; Xue K; Mao C; Chen B; Zhan P; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Nov; 124(1):229-35. PubMed ID: 20204500
[TBL] [Abstract][Full Text] [Related]
30. Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin's lymphoma: evidence from a meta-analysis.
Chen S; Zhu JH; Wang F; Huang SY; Xue WQ; Cui Z; He J; Jia WH
Chin J Cancer; 2015 Mar; 34(3):108-14. PubMed ID: 25962431
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis on the association of nucleotide excision repair gene XPD A751C variant and cancer susceptibility among Indian population.
Mandal RK; Yadav SS; Panda AK
Mol Biol Rep; 2014 Feb; 41(2):713-9. PubMed ID: 24362511
[TBL] [Abstract][Full Text] [Related]
32. [Association of the xeroderma pigmentosum group D DNA repair gene with hepatocellular carcinoma].
Zhang JJ; Ma JZ
Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):683-7. PubMed ID: 23207233
[TBL] [Abstract][Full Text] [Related]
33. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
34. New polymorphisms of Xeroderma Pigmentosum DNA repair genes in myelodysplastic syndrome.
Santiago SP; Junior HLR; de Sousa JC; de Paula Borges D; de Oliveira RTG; Farias IR; Costa MB; Maia ARS; da Nóbrega Ito M; Magalhães SMM; Pinheiro RF
Leuk Res; 2017 Jul; 58():73-82. PubMed ID: 28472728
[TBL] [Abstract][Full Text] [Related]
35. Association of R156R single nucleotide polymorphism of the ERCC2 gene with the susceptibility to ovarian cancer.
Romanowicz H; Michalska MM; Samulak D; Malinowski J; Szaflik T; Bieńkiewicz J; Smolarz B
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():36-40. PubMed ID: 27888704
[TBL] [Abstract][Full Text] [Related]
36. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India.
Sreeja L; Syamala VS; Syamala V; Hariharan S; Raveendran PB; Vijayalekshmi RV; Madhavan J; Ankathil R
J Cancer Res Clin Oncol; 2008 Jun; 134(6):645-52. PubMed ID: 17952468
[TBL] [Abstract][Full Text] [Related]
37. Contribution of XPD (Lys751Gln) and XRCC1 (Arg399Gln) polymorphisms in familial and sporadic breast cancer predisposition and survival: an Indian report.
Syamala VS; Syamala V; Sreedharan H; Raveendran PB; Kuttan R; Ankathil R
Pathol Oncol Res; 2009 Sep; 15(3):389-97. PubMed ID: 19051060
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms of the XRCC1 and XPD genes and breast cancer risk: a case-control study.
Kipikasová L; Wolaschka T; Bohus P; Baumohlová H; Bober J; Blazejová J; Mirossay L; Sarisský M; Mirossay A; Cizmáriková M; Potoceková D; Mojzis J
Pathol Oncol Res; 2008 Jun; 14(2):131-5. PubMed ID: 18415712
[TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.
Zhu H; Cao S; Liu Y; Ding X; Wu Q; Ma H
J Cancer Res Ther; 2013; 9(2):187-92. PubMed ID: 23771356
[TBL] [Abstract][Full Text] [Related]
40. Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis.
Duan XL; Gong H; Zeng XT; Ni XB; Yan Y; Chen W; Liu GL
Asian Pac J Cancer Prev; 2012; 13(7):3299-303. PubMed ID: 22994751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
